XRTX

XORTX Therapeutics
XRTX

6 hedge funds and large institutions have $81.5K invested in XORTX Therapeutics in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$40.1K
2
+$11.6K
3
+$1

Top Sellers

1
-$17.2K
2
-$3.9K
3
-$453
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$255
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$69.9K
XT
2
XTX Topco
Cayman Islands
$11.2K
CA
3
Clearstead Advisors
Ohio
$225
UBS Group
4
UBS Group
Switzerland
$190
SS
5
SBI Securities
Japan
$1
National Bank of Canada
6
National Bank of Canada
Quebec, Canada
–
Raymond James Financial
7
Raymond James Financial
Florida
–
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
–